Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dysport for pain and quality of life in children with cerebral palsy
2017-004497-33Phase 4Terminated
- Sponsor
- Copenhagen University Hospital - Amager and Hvidovre
- Start
- Dec 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of botulinum toxin type A in cerebral palsy (CP) and spasticity, sponsored by Copenhagen University Hospital - Amager and Hvidovre. Primary endpoint: The revised Face, Legs, Activity, Cry, Consolability Scale (r-FLACC). Started Dec 2017; status: terminated.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)spasticity
Beyond the preview
Go deeper on 2017-004497-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-004497-33.